
Ionis (IONS) Collaborates With AstraZeneca for Eplontersen
Published on December 8, 2021
Ionis (IONS) and AstraZeneca (AZN) are set to have joint development and commercialization rights of eplontersen in the United States. AstraZeneca will have exclusive rights to commercialize it in the...
